Page last updated: 2024-10-19

phenylpyruvic acid and Hypoparathyroidism

phenylpyruvic acid has been researched along with Hypoparathyroidism in 1 studies

phenylpyruvic acid: RN given refers to parent cpd
phenylpyruvate : A 2-oxo monocarboxylic acid anion resulting from deprotonation of the carboxy group of either keto- or enol-phenylpyruvic acid.
keto-phenylpyruvic acid : A 2-oxo monocarboxylic acid that is 3-phenylpropanoic acid substituted by an oxo group at position 2. It is an intermediate metabolite in the phenylalanine pathway.

Hypoparathyroidism: A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
AKISAWA, J1

Other Studies

1 other study available for phenylpyruvic acid and Hypoparathyroidism

ArticleYear
[CLINICAL STUDIES ON THE INTERMEDIARY METABOLISM OF TYROSINE. 3. URINARY EXCRETION ON INTERMEDIARY METABOLITES OF TYROSINE IN PATIENTS WITH SOME ENDOCRINE DISEASES AND THE RELATED DISORDERS].
    Naika hokan. Japanese archives of internal medicine, 1964, Volume: 11

    Topics: Addison Disease; Biomedical Research; Diabetes Mellitus; Endocrine System Diseases; Humans; Hypercho

1964